For example, a patient presenting with SCAD who is found to have a pathogenic variant in COL3A1 should undergo a comprehensive evaluation for any additional signs and symptoms associated with vascular Ehlers-Danlos syndrome. This evidence concerns the gene COL3A1 and Ehlers-Danlos syndrome, vascular type.